ArticleLaryngoscope investigative otolaryngology2026
Context-Dependent
Article in Laryngoscope investigative otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Objectives: Mutant p53 (mutp53) proteins can exhibit oncogenic gain-of-function (GOF) activities that promote tumor progression; however, the mechanisms underlying context-dependent mutp53 GOF remain poorly understood. We investigated the functional interactions between Methods: Isogenic UM-SCC-1 HNSCC cell lines expressing mutp53 R175H or G245D, alone or in combination with constitutively active PIK3CA H1047R, were generated. Functional assays were performed to assess invasive growth in vitro and metastatic potential in vivo. Optical genome mapping was used to characterize genomic alterations across the engineered cell lines. Results: PI3K activation (PIK3CA H1047R) alone increased primary tumor growth in vivo but did not promote invasive growth in vitro or metastasis in vivo, whereas mutp53 G245D, but not mutp53 R175H, promoted invasive growth in vitro and metastasis in vivo in addition to enhancing primary tumor growth, indicating that primary tumor growth and invasion/metastasis are separable, context-dependent GOF phenotypes in this model. Genomic analyses revealed distinct patterns of alteration among the engineered models: mutp53 R175H and PI3K activation primarily induced chromosomal number variations, whereas mutp53 G245D drove qualitative genomic alterations, including chromosomal insertions, deletions, and translocations. These qualitative genomic changes strongly correlated with the observed GOF phenotypes. Conclusion: In this isogenic UM-SCC-1 HNSCC model, mutp53 GOF was highly context-dependent, varying between the two p53 mutations examined (R175H vs. G245D), and was linked to distinct patterns of genomic instability. In particular, mutp53 G245D-associated qualitative genomic alterations may underlie its oncogenic activity, suggesting that mutp53-driven genomic instability may represent one mechanism associated with context-dependent GOF phenotypes. Level of Evidence: 5.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.